| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |